卡尔加里大学

2023年6月1日

信息图表2023 IBD的影响在加拿大的报告(CNW集团/克罗恩氏和结肠炎加拿大)(注:炎症性肠病(IBD)描述了一群条件下,两种主要形式的克罗恩病和溃疡性结肠炎。这些自身免疫性疾病引起炎症,溃疡和出血的肠,可以扩展到身体的其他部位。炎症性肠病是一种完全不同的疾病从肠易激综合症(IBS),而不会导致明显的炎症或溃疡肠)。需要解决的报告包括发现改善人的生活与这些疾病的影响:在加拿大的人数与IBD迅速增加:2023年有322600人(占总数的0.8%)增加到470000年的2035(1.1%的人口)2023年将有11000人确诊每48分钟(1)2035年和14000年(1每38分钟)新诊断的数量上升最快在6岁以下儿童。他们和他们的家庭面临特殊挑战随着年龄的老年人是最快速增长的自由于更好的治疗炎症性肠病的人活得更长,我们的人口老龄化的社会经济地位较低,居住在农村,远程和北部社区和土著人民面临额外的障碍护理博士埃里克•Benchimol报告主席,儿科和临床流行病学教授和多伦多大学的高级冰核心科学家和高级科学家和北桥金融公司的椅子在IBD儿童医院(SickKids)在多伦多,表示:“我们看到对心理健康有显著影响,精神疾病是IBD患者常见的1.5 - 2倍。青年与IBD近一倍精神病诊断的风险。这突显出提供精神卫生服务的重要性,尤其是在儿童,青少年和年轻的成年人。”Dr. Gilaad Kaplan, a Professor of Medicine, adult, gastroenterologist, epidemiologist at the University of Calgary and report co-chair, says: "The number of people in Canada living with IBD is growing rapidly. Healthcare needs to evolve to include multidisciplinary care, including access to specialist physicians and nurses, mental health professionals, dietitians and others to improve quality of life." This is the fourth comprehensive report, the first was published in 2008. They bring together experts to provide a comprehensive overview of the impact of IBD in Canada. The 2023 report is available at crohnsandcolitis.ca/2023report . Lori Radke, CEO, Crohn's and Colitis Canada, said: "The report highlights the need to use our financial and health care resources as effectively as possible. That's why, since 2016, our PACE network project has brought together leading Canadian hospital centres to develop best practices to help patients. We're hoping that within the next two years, we start seeing these pilot innovations being rolled out across Canada and leading to better care." An innovation for this report was involving patient reviewers. One of them was Léa Caplan of Calgary. She was diagnosed with Crohn's disease in 2020: "IBD has been an important part of my life for the last three years, so I was happy to be one of the dozens of patient partners. It's meaningful to know that this report was prepared with individuals living with IBD and is for individuals living with IBD. Our voices are being heard." About Crohn's and Colitis Canada We are on a relentless journey to transform the lives of people affected by Crohn's disease and ulcerative colitis by delivering impact at all stages of life, in every corner of the country, by finding the cures for these lifelong diseases, and improving the quality of life of everyone affected by these diseases. Our 2023-2026 Impact Strategy creates a roadmap for our journey with a focus on accelerating the impact of research – address key gaps and success factors; shorten the timeline from discovery to patient impact reaching further – help more people with Crohn's and colitis and their caregivers with our wide range of programs boosting awareness and understanding – engage and motivate Canadians driving system change – advocate and partner to influence change SOURCE Crohn's and Colitis Canada For further information: Paul Kilbertus, Senior Manager, Communications and PR, Crohn's and Colitis Canada, [email protected] , 647-567-4690 ×